financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Tyson Foods Fiscal Q1 Adjusted Earnings, Sales Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tyson Foods Fiscal Q1 Adjusted Earnings, Sales Rise
Feb 3, 2025 5:06 AM

07:37 AM EST, 02/03/2025 (MT Newswires) -- Tyson Foods ( TSN ) reported fiscal Q1 adjusted earnings Monday of $1.14 per share, up from $0.69 a year earlier.

Analysts polled by FactSet expected $0.90.

Sales for the quarter ended Dec. 28 were $13.62 billion, compared with $13.32 billion a year earlier.

Analysts surveyed by FactSet expected $13.46 billion.

The company's shares were up 4% in recent Monday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Realty Income Keeps Monthly Dividend at $0.257 a Share, Payable May 15 to Holders of Record May 1
--Realty Income Keeps Monthly Dividend at $0.257 a Share, Payable May 15 to Holders of Record May 1
Apr 9, 2024
04:34 PM EDT, 04/09/2024 (MT Newswires) -- Price: 54.37, Change: -0.01, Percent Change: -0.02 ...
 WD-40 Company Fiscal Q2 Earnings Decline, Sales Increase; Lifts Full-Year Earnings Forecast
WD-40 Company Fiscal Q2 Earnings Decline, Sales Increase; Lifts Full-Year Earnings Forecast
Apr 9, 2024
04:33 PM EDT, 04/09/2024 (MT Newswires) -- WD-40 Company ( WDFC ) reported fiscal Q2 earnings late Tuesday of $1.14 per diluted share, down from $1.21 a year earlier. Analysts polled by Capital IQ expected $1.13. Net sales for the quarter ended Feb. 29 was $139.1 million, up from $130.2 million a year earlier. Analysts surveyed by Capital IQ expected...
 Apellis Pharmaceuticals Insider Sold Shares Worth $3,743,605, According to a Recent SEC Filing
Apellis Pharmaceuticals Insider Sold Shares Worth $3,743,605, According to a Recent SEC Filing
Apr 9, 2024
04:33 PM EDT, 04/09/2024 (MT Newswires) -- Pascal Deschatelets, Chief Scientific Officer, on April 08, 2024, sold 69,107 shares in Apellis Pharmaceuticals ( APLS ) for $3,743,605. Following the Form 4 filing with the SEC, Deschatelets has control over a total of 1,115,983 shares of the company, with 1,115,983 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1492422/000112760224012710/xslF345X03/form4.xml ...
 Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Apr 9, 2024
(Corrects headline to say Dhingra is a former executive at Summit Therapeutics ( SMMT )) (Reuters) -Illumina ( ILMN ) said on Tuesday Chief Financial Officer Joydeep Goswami would leave the gene sequencing company and would be succeeded by former Summit Therapeutics' executive Ankur Dhingra. Goswami, who has more than two decades of experience in the life sciences industry, was...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2025 - www.financetom.com All Rights Reserved